SAP Expands Pharma Footprint with AstraZeneca Partnership

Share this article
Share this article
Prioritise Us on Google
AstraZeneca is a truly global life sciences organisation, operating in more than 100 countries worldwide. Credit: AstraZeneca
SAP’s Manos Raptopoulos outlines how AstraZeneca’s cloud migration will establish a trusted data foundation and accelerate AI adoption across operations

AstraZeneca is embarking on a major enterprise technology transformation with SAP, migrating its existing ERP landscape to SAP Cloud ERP Private through RISE with SAP as it looks to streamline operations, improve decision-making and accelerate AI adoption.

The full-estate migration signals an expansion of a relationship developed over more than 20 years, with AstraZeneca aiming to standardise its global enterprise technology landscape, harmonise data and establish a more agile, resilient digital foundation. 

Forming part of AstraZeneca’s Axial Business Transformation Programme, it aims to migrate legacy SAP ERP Central Component environments towards a cloud-based platform.

For a global pharmaceutical business operating across the life sciences value chain from research and manufacturing to supply chains and commercial operations, connecting systems and standardising processes is central to improving efficiency and operational visibility. 

AstraZeneca’s transformation aims to enable the company to act on insights faster and create greater value for both its business and patients.

Chris Taylor, Group Chief Information Officer at AstraZeneca. Credit: LinkedIn

“SAP has been a key part of how we run our operations for more than two decades,” says Chris Taylor, Chief Information Officer at AstraZeneca. 

“This next chapter of our partnership is about much more than modernising technology. Through Axial, we are simplifying how AstraZeneca operates and creating the foundations to move faster and unlock greater value from AI. That matters because the faster we can turn insight into action, the faster we can create value for our company and for patients.”

AstraZeneca is not alone in using SAP to modernise pharmaceutical operations, with Moderna, Pfizer and Roche also leveraging SAP technologies to connect manufacturing, finance and supply chain processes, strengthen traceability and improve operational efficiency across their global businesses.

SAP & AstraZeneca: Key facts
  • 20+ years: The length of SAP and AstraZeneca's existing technology partnership.
  • Full-estate migration: AstraZeneca is moving its legacy SAP ERP Central Component (ECC) environments to SAP Cloud ERP Private through RISE with SAP.
  • Three AI priorities: AstraZeneca is exploring SAP's Industry AI portfolio, Joule and agentic AI applications across finance, supply chain and manufacturing.
  • Zero-copy data sharing: SAP Business Data Cloud aims to reduce unnecessary data movement and duplication while preserving business context across datasets.
  • Major pharma customers: Moderna, Pfizer, Roche and Takeda also use SAP technologies to support enterprise transformation, manufacturing and supply chain operations.

Building a trusted, unified data foundation 

Unifying data from across manufacturing, supply chains and business functions requires more than migrating systems to the cloud; organisations must also ensure data is consistent, governed and accessible in the right context.

Speaking to Healthcare Digital, Manos Raptopoulos, Global President Customer Success Europe, APAC, Middle East & Africa and Member of the Extended Board, SAP SE, explains that: “Pharmaceutical companies do not lack data. The challenge is connecting it, particularly when information is spread across legacy systems. 

Manos Raptopoulos, Global President Customer Success Europe, APAC, Middle East & Africa and Member of the Extended Board, SAP SE. Credit: LinkedIn

“From tracking medicines through complex supply chains to maintaining strict quality standards in manufacturing, accurate information is needed at every stage, and fragmentation makes that harder to achieve.”

In a highly regulated industry, that also means upholding strong governance and compliance across operations. 

SAP Business Data Cloud addresses this by “unifying and governing SAP and third-party data in a harmonised model, keeping semantics and business context intact to support a trusted data foundation for more reliable AI and decision-making. 

“Its zero-copy share approach also helps simplify complex landscapes by reducing unnecessary data movement and duplication.”

For AstraZeneca specifically, SAP Business Data Cloud can support the company in building a “clean data core, bringing together disparate datasets to create a trusted foundation for future AI adoption.” 

“Pharmaceutical companies do not lack data. The challenge is connecting it, particularly when information is spread across legacy systems. ”
Manos RaptopoulosGlobal President Customer Success Europe, APAC, Middle East & Africa and Member of the Extended Board, SAP SE

SAP and AstraZeneca explore enterprise AI

With its cloud transformation laying the groundwork for greater connectivity, AstraZeneca is also exploring SAP’s wider Business AI portfolio, including Industry AI capabilities, Joule and agentic AI use cases across finance, supply chain and manufacturing.

These applications could help improve productivity, strengthen data quality and governance, and support faster, more informed decision-making across the business. 

Connecting enterprise data with AI tools is particularly critical for pharmaceutical organisations, where operational decisions must balance efficiency, accuracy and stringent regulatory requirements.

Youtube Placeholder

The partnership also extends to sustainability data. Through SAP Green Ledger, AstraZeneca can connect sustainability and business information across its value chain, helping integrate environmental considerations into operational processes and business decisions.

“Across the life sciences and healthcare industry, companies are rethinking how technology can help them manage complexity and drive greater value,” explains Manos in the official partnership announcement.

“AstraZeneca’s Axial Transformation Programme shows how cloud, data and AI can create a stronger foundation for innovation at scale," he continues. "By helping simplify operations, enable faster decisions and unlock trusted insights, we can support AstraZeneca as it works to push the boundaries of science to deliver life-changing medicines to patients worldwide.”

Other life sciences SAP customers

- Moderna: The US biotechnology company uses SAP S/4HANA as part of its digital enterprise infrastructure, integrating finance, procurement, inventory and manufacturing processes as it scaled its mRNA platform. SAP technologies have also supported vaccine serialisation, traceability and distribution, helping Moderna manage global supply chain requirements and regulatory compliance.

- Pfizer: Pfizer has undertaken a major SAP ERP transformation, migrating its legacy environment to SAP S/4HANA to modernise finance, business operations and supply chain processes. The programme involved selectively migrating data from an 85-terabyte legacy system, helping simplify its enterprise architecture, improve performance and strengthen its global digital infrastructure. 

- Roche: Roche uses SAP technologies to strengthen supply chain efficiency, data management and manufacturing operations. Its work with SAP HANA and analytics solutions has helped improve material master data management, reduce duplication, strengthen compliance and support more informed decision-making across its pharmaceutical operations. 

- Takeda: Takeda is working with SAP to integrate manufacturing, supply chain and research and development processes across its global operations. The partnership is exploring AI-enabled workflows and autonomous regulated manufacturing, with SAP Cloud ERP and Joule supporting ambitions to embed predictive insights, quality controls and more accessible business data into operational decision-making.

Executives